Former Chief Executive Officer & President · GALECTIN THERAPEUTICS INC (GALT)

Peter Traber

A named executive officer of GALECTIN THERAPEUTICS in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,308,609

Salary $270,211Stock awards $0

FY2017: $877,389

2nd of 3 named executive officers at Galectin Therapeutics by FY2018 total.

3 named officers on file for GALECTIN THERAPEUTICS, FY2018

Peter Traber’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how GALECTIN THERAPEUTICS’s whole pay program stands against its peers

  • GALECTIN THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GALT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 17, 2019 (DEF 14A).

Free

Get Peter Traber’s full pay file as a PDF — free

More than this page: up to 10 years of Peter’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Peter Traber compensation by year

GALECTIN THERAPEUTICS Summary Compensation Table · all 3 fiscal years held
In US dollars, as GALECTIN THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$512,500$512,500$270,211
Bonus$160,877$299,492$0
Stock awards$0$0$0
Option awards$288,136$0$993,499
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$60,567$65,397$44,899
Total$1,022,080$877,389$1,308,609

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GALECTIN THERAPEUTICS INC DEF 14A filed October 17, 2019, accession 0001193125-19-268920, and prior-year filings. Open the filing on EDGAR.

How this page was built: the GALECTIN THERAPEUTICS INC filed document, accession 0001193125-19-268920. Every figure is read from that document and cited to the page and table it appears in. Filed October 17, 2019.

$1.0M
$877K
$1.3M
FY16
FY17
FY18
SalaryBonusOption awardsAll other

GALECTIN THERAPEUTICS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Harold ShlevinChief Executive Officer & President$1,730,815
Peter Traber · this pageFormer Chief Executive Officer & President$1,308,609
Jack CallicuttChief Financial Officer$1,266,497

The full GALECTIN THERAPEUTICS compensation record

free company brief

This page is one person within GALECTIN THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GALECTIN THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Peter Traber's compensation dossier · One-time report. No refunds.